Literature DB >> 20381746

The lamellar wedge.

Simon N Collins1, Andrew W van Eps, Christopher C Pollitt, Atsutoshi Kuwano.   

Abstract

In horses with chronic laminitis, an abnormal horn structure called the lamellar wedge develops within the lamellar region of the foot. This pathologic structure adversely affects normal foot function, and influences return to previous performance levels. Understanding the pathologic process that leads to the development of this structure is essential for correct supportive foot management of the horse with chronic laminitis. The ability to prevent or reduce the formation of the lamellar wedge may eventually lead to better outcomes in cases of laminitis. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20381746     DOI: 10.1016/j.cveq.2010.01.004

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  4 in total

1.  Expression and localization of epithelial stem cell and differentiation markers in equine skin, eye and hoof.

Authors:  Renata L Linardi; Susan O Megee; Sarah R Mainardi; Makoto Senoo; Hannah L Galantino-Homer
Journal:  Vet Dermatol       Date:  2015-05-12       Impact factor: 1.589

2.  The expression of equine keratins K42 and K124 is restricted to the hoof epidermal lamellae of Equus caballus.

Authors:  Caitlin Armstrong; Lynne Cassimeris; Claire Da Silva Santos; Yagmur Micoogullari; Bettina Wagner; Susanna Babasyan; Samantha Brooks; Hannah Galantino-Homer
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

3.  Pituitary Pars Intermedia Dysfunction and Metabolic Syndrome in Donkeys.

Authors:  Heidrun Gehlen; Bianca Schwarz; Claus Bartmann; Jennifer Gernhardt; Sabita D Stöckle
Journal:  Animals (Basel)       Date:  2020-12-08       Impact factor: 2.752

4.  Interleukin-17A pathway target genes are upregulated in Equus caballus supporting limb laminitis.

Authors:  Lynne Cassimeris; Julie B Engiles; Hannah Galantino-Homer
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.